One Week of Oral Camostat Versus Placebo in Nonhospitalized Adults With Mild-to-Moderate Coronavirus Disease 2019: A Randomized Controlled Phase 2 Trial.
| Autor: | Jilg, Nikolaus1 njilg@mgh.harvard.edu, Chew, Kara W2, Giganti, Mark J3, Daar, Eric S4, Wohl, David A5, Javan, Arzhang Cyrus6, Kantor, Amy3, Moser, Carlee3, Coombs, Robert W7, Neytman, Gene8, Hoover, Keila9, Jana, Atasi10, Hart, Phil A11, Greninger, Alexander L7, Szurgot, Bob10, Eron, Joseph J5, Currier, Judith S12, Hughes, Michael D3, Smith, Davey M13, Li, Jonathan Z14 |
|---|---|
| Zdroj: | Clinical Infectious Diseases. Oct2023, Vol. 77 Issue 7, p941-949. 9p. |
| Databáze: | Academic Search Ultimate |
| Externí odkaz: |
|